Follow‐up actions from positive results of in vitro genetic toxicity testingKerry L. Dearfield, Kristine L. Witt, Gladys Ouédraogo‐Arras et al.|Environmental and Molecular Mutagenesis|2010Cited by 60
Qualification of impurities based on metabolite dataLars Weidolf, Bruce A. Trela, Thomas Andersson et al.|Regulatory Toxicology and Pharmacology|2019Cited by 20
N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulationsAnthony M Lynch, John W. Wills, Jonathan Howe et al.|Mutagenesis|2024Cited by 20
N-Nitrosamine drug substance related impurities (NDSRIs) – A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 DaJoel P. Bercu, Mike W Urquhart, Olivier Dirat et al.|Regulatory Toxicology and Pharmacology|2024Cited by 14
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakesDavid J. Ponting, Robert Thomas, Andreas Czich et al.|Regulatory Toxicology and Pharmacology|2024Cited by 13